Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-30T20:24:19.975Z Has data issue: false hasContentIssue false
  • English
  • Français

New Developments in Infection Control

Published online by Cambridge University Press:  02 January 2015

Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Departments
Information
Infection Control & Hospital Epidemiology , Volume 1 , Issue 5 , October 1980 , pp. 297 - 308
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1980

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bahmanyar, M, Fayaz, A, Nour-Salehi, S, Mohammadi, M, Koprowski, H. Successful protection of humans exposed to rabies infection: postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum. JAMA 1976;236:2751-4.CrossRefGoogle ScholarPubMed
Corey, L, Hattwick, MAW. Treatment of persons exposed to rabies. JAMA 1975;232:272-6.CrossRefGoogle ScholarPubMed
Greenberg, M, Childress, J. Vaccination against rabies with duck embryo and Semple vaccine. JAMA 1960;173:333-7.CrossRefGoogle Scholar
Hattwick, MAW. Human rabies. Public Health Reviews 1974;2:229-75.Google Scholar
Hattwick, MAW, Rubin, RH, Music, S, Sikes, RK, Smith, JS, Gregg, MB. Postexposure rabies prophylaxis with human rabies immune globulin. JAMA 1974;227:407-10.CrossRefGoogle ScholarPubMed
Johnson, HN. Rabies virus. In: Horsfall, FL, Tamm, I, eds. Viral and rickettsial infections of man, 4th ed. Philadelphia: JB Lippincott, 1965;814-40.Google Scholar
Peck, FM Jr, Powell, HM, Culbertson, CG. A new antirabies vaccine for human use. J Lab Clin Med 1955;45:679-83.Google ScholarPubMed
Rubin, RH, Hattwick, MAW, Jones, S, Gregg, MB, Schwartz, VD. Adverse reactions to duck embryo rabies vaccine; range and incidence. Ann Intern Med 1973;78:643-49.CrossRefGoogle ScholarPubMed
Tierkel, ES, Sikes, RK: Preexposure prophylaxis against rabies: comparison of regimens. JAMA 1967;201:911-14.CrossRefGoogle ScholarPubMed
Tint, H, Rosanoff, EI. Clinical responses to T(N) BP — disrupted HDCS (WI-38) rabies vaccine. Dev Biol Stand 1977;37:287-9.Google Scholar
Wiktor, TJ, Plotkin, SA, Koprowski, H. Development and clinical trials of the new human rabies vaccine of tissue culture (human diploid cell) origin. Dev Biol Stand 1978;40:3–9.Google ScholarPubMed
World Health Organization. Sixth report of the Expert Committee on Rabies. Geneva, Switzerland: World Health Organization, 1973. (WHO Tech Rep No. 523).Google Scholar
Working Group 2, World Health Organization. Vaccine potency requirements for reduced immunization schedules and pre-exposure treatment. Dev Biol Stand 1978;40:268-70.Google Scholar
Anderson, LJ, Sikes, RK, Langkop, CW, et al. Postexposure trial of a human diploid cell strain rabies vaccine. J Infect Dis (in press).Google Scholar